EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study

Osamu Nishida, Tomoyuki Nakamura iD, Takaaki Nakada iD, Gaku Takahashi, Yoshiki Masuda, Hiroki Tsubouchi, Yasuyuki Kakihana, Yuichiro Sakamoto, Osamu Takasu, Hiroyuki Suzuki, Koichi Nakazawa, Iwao Kobayashi und 9 weitere

Artificial Organs · 2025

DOI: 10.1111/aor.14943 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Artificial Organs, 2025. Verfasst von Osamu Nishida und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Sepsis, Granulocytes, Monocytes, Hemoperfusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JIMRO CO. LTD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pathogenesis of sepsis is thought to be linked to a dysregulated immune response, particularly that involving neutrophils. We have developed a granulocyte adsorption column as a “decoy organ,” which relocates the massive inflammation in organs in the body to a blood purification column. This study was conducted to assess the safety and experimental effectiveness of granulocyte monocyte adsorption apheresis‐direct hemoperfusion (G1‐DHP) in the treatment of patients with sepsis, using a prospective, multicenter design.

Methods

The study included patients diagnosed with sepsis and with an APACHE II score ranging from 17 to 34. A total of five G1‐DHP were performed within 3 days of patient enrollment. The primary endpoint was the change in sequential organ failure assessment (SOFA) score from enrollment to 7 days, and the safety endpoints were adverse events and mortality at 28 days.

Results

G1‐DHP was performed on 82 patients. The median (interquartile range) SOFA score decreased from 10 (8–11) to 4 (3–7) after 7 days ( n = 70; p < 0.01). Granulocytes, mainly neutrophils, were adsorbed, and the neutrophil‐to‐lymphocyte ratio significantly improved ( p < 0.01). Notable improvements were observed in the SOFA scores for circulation and renal function. The acute physiology and chronic health evaluation II score of the 77 patients evaluated for mortality was 27, and the 28‐day mortality rate was 7.8%.

Conclusions

This study confirmed that G1‐DHP can be safely used as an adjunct to standard sepsis treatment regimens. Although further investigations are required, G1‐DHP is a promising supplemental therapy for sepsis. Trial Registration: jRCT1080225183 (Japan Registry of Clinical Trials identifier)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisGranulocytesMonocytesHemoperfusionHumansMaleFemaleMiddle AgedAgedFeasibility StudiesProspective StudiesAdsorptionOrgan Dysfunction ScoresAPACHETreatment Outcome

Stichwörter der Autor:innen

adacolumncytokinehemoadsorptionneutrophilssepsissequential organ failure assessment

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Emergency and Critical Care Medicine, Chiba University, Chiba, Japan.
  • Department of Critical Care and Emergency, Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University, Shiwa, Japan.
  • Department of Intensive Care Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Anesthesiology and Intensive Care, Ichinomiyanishi Hospital, Ichinomiya, Japan.
  • Department of Emergency and Intensive Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

ORCID-Profile: Tomoyuki Nakamura, Takaaki Nakada, Toru Kotani, Yasushi Suzuki, Kazuhiro Moriyama

Förderung

  • JIMRO CO. LTD

Zitieren

APA

Nishida, O., Nakamura, T., Nakada, T., Takahashi, G., Masuda, Y., Tsubouchi, H., Kakihana, Y., Sakamoto, Y., Takasu, O., Suzuki, H., Nakazawa, K., Kobayashi, I., Doi, K., Uchiyama, S., Kitamura, N., Kotani, T., Kuriyama, N., Hattori, N., Suzuki, Y., …, & Moriyama, K. (2025). Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study. Artificial Organs. https://doi.org/10.1111/aor.14943

Vancouver

Nishida O, Nakamura T, Nakada T, Takahashi G, Masuda Y, Tsubouchi H, et al. Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study. Artificial Organs. 2025. doi:10.1111/aor.14943

BibTeX
@article{Nishida2025,
  author = {Nishida, Osamu and Nakamura, Tomoyuki and Nakada, Takaaki and Takahashi, Gaku and Masuda, Yoshiki and Tsubouchi, Hiroki and Kakihana, Yasuyuki and Sakamoto, Yuichiro and Takasu, Osamu and Suzuki, Hiroyuki and Nakazawa, Koichi and Kobayashi, Iwao and Doi, Kent and Uchiyama, Sohta and Kitamura, Nobuya and Kotani, Toru and Kuriyama, Naohide and Hattori, Noriyuki and Suzuki, Yasushi and Tatsumi, Hiroomi and Moriyama, Kazuhiro},
  title = {Granulocyte and Monocyte Adsorption Therapy in Patients With Sepsis: A Feasibility Study},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.14943}
}
Kostenlos starten →